ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ.
暂无分享,去创建一个
M. Molloy | B. Shi | I. Blair | Shu Yang | L. Ittner | Y. Ke | R. Chung | Carol G. Au | M. Morsch | Albert Lee | N. Grima | F. Cheng | S. Rayner | J. Davidson | Alana De Luca | A. Hogan
[1] Jie Huang,et al. The Emerging Role of the RNA-Binding Protein SFPQ in Neuronal Function and Neurodegeneration , 2020, International journal of molecular sciences.
[2] Amy K. Cain,et al. SFPQ intron retention, reduced expression and aggregate formation in central nervous system tissue are pathological features of amyotrophic lateral sclerosis , 2020, bioRxiv.
[3] C. van Broeckhoven,et al. Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum , 2020, Neurobiology of Disease.
[4] K. Nakayama,et al. Pathogenic mutations in the ALS gene CCNF cause cytoplasmic mislocalization of Cyclin F and elevated VCP ATPase activity. , 2019, Human molecular genetics.
[5] A. Walker,et al. Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD , 2019, Front. Neurosci..
[6] M. Pagano,et al. Cyclin F Controls Cell-Cycle Transcriptional Outputs by Directing the Degradation of the Three Activator E2Fs. , 2019, Molecular cell.
[7] M. Molloy,et al. Using proteomics to identify ubiquitin ligase–substrate pairs: how novel methods may unveil therapeutic targets for neurodegenerative diseases , 2019, Cellular and Molecular Life Sciences.
[8] M. Molloy,et al. Pathogenic mutation in the ALS/FTD gene, CCNF, causes elevated Lys48-linked ubiquitylation and defective autophagy , 2019, Cellular and Molecular Life Sciences.
[9] C. van Broeckhoven,et al. ALS Genes in the Genomic Era and their Implications for FTD. , 2018, Trends in genetics : TIG.
[10] J. Ule,et al. Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS , 2018, Nature Communications.
[11] B. Burke,et al. BioID: A Screen for Protein‐Protein Interactions , 2018, Current protocols in protein science.
[12] M. Molloy,et al. Casein kinase II phosphorylation of cyclin F at serine 621 regulates the Lys48-ubiquitylation E3 ligase activity of the SCF(cyclin F) complex , 2017, Open Biology.
[13] T. Fath,et al. Tau exacerbates excitotoxic brain damage in an animal model of stroke , 2017, Nature Communications.
[14] I. Blair,et al. Cyclin F: A component of an E3 ubiquitin ligase complex with roles in neurodegeneration and cancer. , 2017, The international journal of biochemistry & cell biology.
[15] Chadwick M. Hales,et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD , 2017, Alzheimer's & Dementia.
[16] B. Ueberheide,et al. Cyclin F-Mediated Degradation of SLBP Limits H2A.X Accumulation and Apoptosis upon Genotoxic Stress in G2. , 2016, Molecular cell.
[17] Michael J. Emanuele,et al. APC/C and SCF(cyclin F) Constitute a Reciprocal Feedback Circuit Controlling S-Phase Entry. , 2016, Cell reports.
[18] Robert H. Brown,et al. CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia , 2016, Nature Communications.
[19] J. Rappsilber,et al. SCFCyclin F-dependent degradation of CDC6 suppresses DNA re-replication , 2016, Nature Communications.
[20] Sripriya Ravindra Kumar,et al. Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain , 2015, Nature Biotechnology.
[21] Edward L. Huttlin,et al. Quantitative Proteomic Atlas of Ubiquitination and Acetylation in the DNA Damage Response. , 2015, Molecular cell.
[22] Amber L. Couzens,et al. BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates* , 2015, Molecular & Cellular Proteomics.
[23] Swneke D. Bailey,et al. BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. , 2015, Journal of proteomics.
[24] J. Rappsilber,et al. Cyclin F suppresses B-Myb activity to promote cell cycle checkpoint control , 2015, Nature Communications.
[25] V. Doye,et al. Probing nuclear pore complex architecture with proximity-dependent biotinylation , 2014, Proceedings of the National Academy of Sciences.
[26] Lorne Zinman,et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis , 2014, Nature Neuroscience.
[27] C. V. Van Itallie,et al. Biotin ligase tagging identifies proteins proximal to E-cadherin, including lipoma preferred partner, a regulator of epithelial cell–cell and cell–substrate adhesion , 2014, Journal of Cell Science.
[28] D. Vilchez,et al. The Mechanistic Links Between Proteasome Activity, Aging and Age-related Diseases , 2014, Current genomics.
[29] C. Troakes,et al. Compromised paraspeckle formation as a pathogenic factor in FUSopathies , 2013, Human molecular genetics.
[30] H. Okano,et al. The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis , 2013, Molecular Brain.
[31] C. V. Van Itallie,et al. The N and C Termini of ZO-1 Are Surrounded by Distinct Proteins and Functional Protein Networks* , 2013, The Journal of Biological Chemistry.
[32] Michael Benatar,et al. Prion-like domain mutations in hnRNPs cause multisystem proteinopathy and ALS , 2013, Nature.
[33] M. Pagano,et al. Cyclin F-Mediated Degradation of Ribonucleotide Reductase M2 Controls Genome Integrity and DNA Repair , 2012, Cell.
[34] A. Levey,et al. Quantitative analysis of the detergent-insoluble brain proteome in frontotemporal lobar degeneration using SILAC internal standards. , 2012, Journal of proteome research.
[35] Brian Burke,et al. A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells , 2012, The Journal of cell biology.
[36] Michael J. Emanuele,et al. Global Identification of Modular Cullin-RING Ligase Substrates , 2012, Cell.
[37] S. Ajroud‐Driss,et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. , 2011, Archives of neurology.
[38] J. Haines,et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia , 2011, Nature.
[39] E. Huey,et al. FTD and ALS: a tale of two diseases. , 2011, Current Alzheimer research.
[40] M. Pagano,et al. SCFCyclin F controls centrosome homeostasis and mitotic fidelity via CP110 degradation , 2010, Nature.
[41] D. Cleveland,et al. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. , 2010, Human molecular genetics.
[42] C. Bond,et al. Paraspeckles: nuclear bodies built on long noncoding RNA , 2009, The Journal of cell biology.
[43] J L Haines,et al. Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .
[44] Xun Hu,et al. Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.
[45] Xun Hu,et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.
[46] A. Pestronk,et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein , 2004, Nature Genetics.
[47] M. Molloy,et al. Expression of ALS/FTD-linked mutant CCNF in zebrafish leads to increased cell death in the spinal cord and an aberrant motor phenotype , 2017, Human molecular genetics.
[48] Jürgen Götz,et al. Primary support cultures of hippocampal and substantia nigra neurons , 2008, Nature Protocols.